((8R,9R,10S,13S,14S,17R)-17-(1-HYDROXYETHYL)-13-METHYL-16-METHYLENE-3-OXO-2,4,5,6,7,8,9,10,11,12,14,15-DODECAHYDRO-1H-CYCLOPENTA(A)PHENANTHREN-17-YL) ACETATE
UNII N4987H8KH5
Substance Identification & Data
This profile provides standardized clinical and technical data for ((8r,9r,10s,13s,14s,17r)-17-(1-hydroxyethyl)-13-methyl-16-methylene-3-oxo-2,4,5,6,7,8,9,10,11,12,14,15-dodecahydro-1h-cyclopenta(a)phenanthren-17-yl) Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N4987H8KH5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H34O4 ZDRKRPHQJSRONC-XTIWAPHOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for ((8r,9r,10s,13s,14s,17r)-17-(1-hydroxyethyl)-13-methyl-16-methylene-3-oxo-2,4,5,6,7,8,9,10,11,12,14,15-dodecahydro-1h-cyclopenta(a)phenanthren-17-yl) Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.